Results 271 to 280 of about 46,348 (289)
Some of the next articles are maybe not open access.
2010
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME.
Bandello, Francesco +6 more
openaire +8 more sources
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have proven to be useful in the detection and the monitoring of the features characterizing DME.
Bandello, Francesco +6 more
openaire +8 more sources
International Ophthalmology Clinics, 1976
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
Stuart L. Fine, Arnall Patz
openaire +3 more sources
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
Stuart L. Fine, Arnall Patz
openaire +3 more sources
2014
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Enrico Giacomotti +2 more
openaire +3 more sources
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Enrico Giacomotti +2 more
openaire +3 more sources
Vitrectomy for Diabetic Macular Edema
Ophthalmology, 2010link_to_subscribed_fulltext
Cheung, N, Connell, P, Wong, TY
openaire +4 more sources
Treatment of Diabetic Macular Edema
Current Diabetes Reports, 2019Diabetes mellitus is a global epidemic which is growing in prevalence, and diabetic macular edema (DME) is a leading cause of visual impairment among patients affected by this disease. Our objective is to review current and upcoming therapeutic approaches to DME.Once considered the gold standard in treatment of DME, focal/grid laser is now reserved ...
Weijie V. Lin +5 more
openaire +3 more sources
Ophthalmology, 1986
Diabetic macular edema can be classified into a focal variety, characterized by focal leakage from microaneurysms, often with accumulation of extravascular lipoprotein in a circinate pattern around the focal leakage, and a diffuse variety, with diffuse leakage from retinal vessels often accompanied by cystoid macular changes.
openaire +3 more sources
Diabetic macular edema can be classified into a focal variety, characterized by focal leakage from microaneurysms, often with accumulation of extravascular lipoprotein in a circinate pattern around the focal leakage, and a diffuse variety, with diffuse leakage from retinal vessels often accompanied by cystoid macular changes.
openaire +3 more sources
Photocoagulation for Diabetic Macular Edema
Archives of Ophthalmology, 1987To the Editor. —In the December 1985 issue of theArchiveswe published data from the Early Treatment Diabetic Retinopathy Study (ETDRS) that demonstrated that focal photocoagulation of "clinically significant" diabetic macular edema substantially reduces the risk of visual loss. 1 As part of the ongoing monitoring of the 23 clinics in this study, we
Frederick L. Ferris, Lloyd M. Aiello
openaire +3 more sources
Photocoagulation for Diabetic Macular Edema [PDF]
Archives of Ophthalmology, 1986 To the Editor. —The Early Treatment Diabetic Retinopathy Study Research Group (ETDRS) should be complimented for their efforts in carrying out the randomized clinical trial designed to evaluate photocoagulation and aspirin treatment in the management of patients with nonproliferative diabetic retinopathy.
openaire +2 more sources
Pathophysiology of Diabetic Macular Edema
2007Diabetic maculopathy is the leading cause of visual loss in diabetic patients. The pathogenesis is not fully understood and a satisfactory therapy is currently not available. Malfunction of the blood-retinal barrier plays a central role in the disease and leads to retinal edema and secondary photoreceptor dysfunction.
Neil Smyth +2 more
openaire +3 more sources
Quantification of Diabetic Macular Edema
Archives of Ophthalmology, 1987In a cross-sectional study, 34 diabetic patients with clinically significant macular edema underwent visual acuity testing, stereo fundus photography (graded for retinal thickening and hard exudates), fluorescein angiography (evaluated for macular leakage and the outline of the foveal avascular zone [FAZ]), and vitreous fluorophotometry (whereby ...
José Cunha-Vaz +4 more
openaire +3 more sources